SPERA PHARMA
A Japanese CMC CRO explicitly offering contract 3D ED / MicroED testing for fine crystalline powders, mixtures, salts, cocrystals, and tablets.
Corporate information
- Company entity
- SPERA PHARMA, Inc.
- Headquarters / principal office
- OsakaSelf-reported location on the company LinkedIn page; regional scope may differ from the legal or global headquarters. ↗
- Founded
- 2017 ↗
- Ownership / capital status
- Group subsidiary / business platformCMC services company within the Astena group ↗
- Official corporate reference
- https://www.spera-pharma.co.jp/en/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
The website explicitly offers client 3D ED / MicroED structure analysis and presents a selexipag case study.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.